{"name":"Capstan Therapeutics","slug":"capstan-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE5vRTMwODRQa2k4cFZaOVFmNndFYnVtdF8zODQ5Mk1HeUdfdmZ6NU42a1hFX2xpLWc2QmlxOHl5ZWN2SHNuU25jemtRUFVFUFVFWXdTU3g4V3lCSC1EMlVsOXBn?oc=5","date":"2025-09-02","type":"pipeline","source":"Fierce Pharma","summary":"Laura Shawver - Fierce Pharma","headline":"Laura Shawver","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxPYzdpVVJuaDRZOGtSbnVEVEpPdG54dlVmQVd2RnNSR0tDZ1pmTTBsTmpUSFFudzBpM0R5LXBpTTZDSkd0ckthd0NDZ3hzTmw2SHA1RWtmYlVsNmp0SG0wcGo5MTkzdzUyNHUySXpTdkNGcFlGUUNfMXgxV3BUMFU5a1laa2RYNjF1dGJtdnpwNEVxWi1qRzR0dm15SVpKMi1MUFNVSGREZmpoYmVJNGdjNFVyTUdxS3h4YUthMUxRYUNLOXJWd2NKMHExc1JETGc1aXdlekNzOFFnOUV2eEZfNg?oc=5","date":"2025-08-25","type":"pipeline","source":"Pharmaceutical Executive","summary":"AbbVie Expands Psychiatry Drug Pipeline with Acquisition of Gilgamesh Pharmaceuticals’ Bretisilocin for Major Depressive Disorder - Pharmaceutical Executive","headline":"AbbVie Expands Psychiatry Drug Pipeline with Acquisition of Gilgamesh Pharmaceuticals’ Bretisilocin for Major Depressive","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQOEM3ZGRwRkNWLWpUUTU2bUFJbGdpSFREdmNhbGtJekJkVk5qTEJUbEhmWlF2UFh3OWZPd3pnbHYxUkdCeDNIVU1qZ1lIZ08yOFYyRzYwU21ZOUVJN1FTc0lUa2FVVDVlbzJpb3hHMWNGenBCc3d0ZXV2OXAtU1pRb18yXzhWbXhkTTVPejBzMENsRE9pelc2T3RDTURlWjNQeGJFWVN5eHNIMkQwR044?oc=5","date":"2025-07-01","type":"deal","source":"Pharmaceutical Technology","summary":"AbbVie buys $2.1bn Capstan, adding new in vivo CAR-T to pipeline - Pharmaceutical Technology","headline":"AbbVie buys $2.1bn Capstan, adding new in vivo CAR-T to pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQM2FBX0VhUVNoZmdxSGdpak5aMmNHdkdPN0JXOG1sUkRCLXVHNjJPXzRab3ZzS0JuazVoWGNFQmQteV9uZDdMRHdmcG5RRTRfc0I0S05GYUc2OFEwX2F5SnpDN2x5aUFVWXhqcHZuQ2NObGcyb1Q5b2U2Q0JodzZ2b3N4ZjYtajhRX1VBeQ?oc=5","date":"2025-07-01","type":"deal","source":"pharmaphorum","summary":"AbbVie's $2.1bn buy of Capstan lifts its immunology pipeline - pharmaphorum","headline":"AbbVie's $2.1bn buy of Capstan lifts its immunology pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE8zT1BlUS1GazVsbVRPYV9JZTVRaUR1TFlQbzNuNjI3RngtVHFpN1RIaTNkX18tamxFaV9xc1hBbGl0YXlLMWhZc29BeGxHZmg1bFJJdmIzRGhIaDBxeEVQUnhHTHJyNV9EbjA5aW1pUlZvbnMwR2NNQzQ4TdIBgAFBVV95cUxOd2ltN1d4NlMzajR6bXVXanFTUG82akdTelNHbS1kUTFJSVBCdUhmLXJJTzJMX24wTGZqN3B1aG5FSTJDUDU1aHdteThYTk4yM3pXaUlEeTBNMUs3UEVVTnBGNS1TRVluc0dCOGZjRWVXc3NaanpWOG9yU2JRMUlySA?oc=5","date":"2025-06-30","type":"deal","source":"CNBC","summary":"AbbVie to buy Capstan Therapeutics for up to $2.1 billion - CNBC","headline":"AbbVie to buy Capstan Therapeutics for up to $2.1 billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFB4WktMZW9lNGRWbXY1TXlKREhLTjMwaXdKR25QY2xyU1FuaVpxR0tKQnpVQ3VaY0F4R3BwNFM2T3RzalJxMGVwVHJEdHROX09XczFJ?oc=5","date":"2025-06-30","type":"pipeline","source":"FirstWord Pharma","summary":"AbbVie splashes $2.1B on Capstan's in vivo CAR-T efforts - FirstWord Pharma","headline":"AbbVie splashes $2.1B on Capstan's in vivo CAR-T efforts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPbS1GUThtYmZqbW9DM2NrbnRTRXVrcFNqT3djQkhXVmJBUTd5YzEzOUs5dlF4d081aS1NOXlGX1dwSU9wbElDcE4wRVdlOGxCNDVianR3ZFhLMFNEeUw5UXJCNDBDaWlFU1BlQXduQldMbFZidXNDYlFRWDJmUHNZczRwS1JzT3BSd2thalE1NnJodHRF?oc=5","date":"2025-06-30","type":"deal","source":"BioPharma Dive","summary":"AbbVie to buy CAR-T developer Capstan in deal worth up to $2.1B - BioPharma Dive","headline":"AbbVie to buy CAR-T developer Capstan in deal worth up to $2.1B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPV3htUWN3RXFNelFTbzZ3WkNZelR1MWR5SmdnV2ZZQ2x5VTJWOUdGWmg5NFhtUU8zQm02Nm1nRXZaM09jZmVHTTNkN3EyQ19ucEJael92ZnpzMkkxN19jMWUyUl93c0Q4OWNlSnRRbHVEOHBJamdvUGp2dlJqaDhFRXllaw?oc=5","date":"2025-06-30","type":"deal","source":"statnews.com","summary":"AbbVie snaps up CAR-T company in a deal worth $2.1 billion - statnews.com","headline":"AbbVie snaps up CAR-T company in a deal worth $2.1 billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxONDhtMjQ1eWxiT29pWjdBaTI1ZnVnZDgwSEVkd2RSRTMtamVkQzIzdk50OWR3N2RuUTNVN3RicWJJd1R3SWdFZzZGWkZoRVRuby02YW5fdm16MFBUTjJaeDR6Wk5zX3EzWHp0dVlEb283bGo4WXVKdXBMTzV3c2M2Y1dzWWFMbm9CMzBGSnEwZVE?oc=5","date":"2025-06-30","type":"pipeline","source":"The Pharma Letter","summary":"AbbVie splashes out $2.1 billion on Capstan - The Pharma Letter","headline":"AbbVie splashes out $2.1 billion on Capstan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPWlRkS0E0M2VJNEx6WFNwUmlMQnhlaUo3U25UVnFIV29BdXMzUG84REhXZElxUVpud1hibmZWUmF5ZVhicVN1ZDJqSWFfUlJGU3VpYTJZX1hKNGVZNHFRX2ZxSmxEZUU5VW1xNEdnM1dNZXd4V2tjWjlzY1dsYm1oY2hoczg5NHd2d0VXQ21HX1RHMmFoeUtyQ0xGekVPZl9hTFBXUGNB?oc=5","date":"2025-06-30","type":"deal","source":"Fierce Biotech","summary":"AbbVie reels in Capstan in $2.1B buyout, charting course for in vivo CAR-T market - Fierce Biotech","headline":"AbbVie reels in Capstan in $2.1B buyout, charting course for in vivo CAR-T market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNQzFmRW9DTTQyZzVGVjVkMnZGeGtoVU0wLVlUVmp4UHpPWVVfOU1PdkZkREozQ1pYaUppREh2UENQRDg3QTV5QnlVaHlUQmlCSmtJR2pBZHJYbmtsbHdnSUE5b05rN1NlM3lxRWQxc3Fma2QxRkZfQzVickU1YXllckhWTFdqWko1VWExUXBlMDBpRWVBVmxUbE9ZcmJyTHJScnlMYlAxTm8xTzFwV3NQYVotQlFtSGFC?oc=5","date":"2025-06-30","type":"pipeline","source":"MedCity News","summary":"AbbVie’s $2.1B Acquisition Adds In Vivo Cell Therapy to Its Immunology & Inflammation Pipeline - MedCity News","headline":"AbbVie’s $2.1B Acquisition Adds In Vivo Cell Therapy to Its Immunology & Inflammation Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPYVJYVVRsVUppSC1EVDJmOGJYZzloTnNEY21WenNKa3gwdmdIMXpiZEFCMk5EdUhVNzhUZWNCY2lGRXlPMXBZT3REUUViX0NRc0EtMjlCSVR0MjNtaUZyYW9YakxZcE1iQzg5LWdOUEc0RUt6ZDNYbE1nUzJfRWxFVUJDYVJ2S0g2SE5nelpR?oc=5","date":"2025-06-30","type":"trial","source":"Endpoints News","summary":"AbbVie bags Capstan’s in vivo CAR-T work with $2.1B buyout deal - Endpoints News","headline":"AbbVie bags Capstan’s in vivo CAR-T work with $2.1B buyout deal","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}